ATRO Sets Record Backlog and Expands Margins as Aerospace Demand Drives 12% Sales Growth
Margins Expand Amid 12% Sales Growth and Strong Aerospace Performance
Astronics Corporation (NASDAQ: ATRO) kicked off 2026 with a 12% year-over-year sales increase, climbing to $230.62 million in Q1. This growth was powered primarily by the Aerospace segment and resulted in notable gross margin expansion—from 29.5% to 32.6%. Operating margin almost doubled to 11.8%, while adjusted EBITDA margin rose to 16.4%, reflecting improved operational execution and strong market demand.
The company delivered net income of $25.54 million ($0.67 per diluted share), up dramatically from $9.53 million in the prior-year period. Adjusted EBITDA reached $37.90 million, a 23.3% gain, highlighting efficiency gains and a more profitable sales mix. The Aerospace segment continued to represent the lion’s share of business at nearly 93% of total sales.
| Metric | Q1 2026 | Q1 2025 | % Change |
|---|---|---|---|
| Sales ($M) | 230.62 | 205.94 | +12.0% |
| Gross Margin | 32.6% | 29.5% | +310 bps |
| Operating Margin | 11.8% | 6.4% | +540 bps |
| Net Income ($M) | 25.54 | 9.53 | +168.1% |
| Adjusted EBITDA ($M) | 37.90 | 30.74 | +23.3% |
| Book-to-Bill Ratio | 1.26 | 1.00 (TTM) |
Record Bookings and Backlog Signal Sustained Demand for Aerospace and Test Segments
Astronics reported record quarterly bookings of $290.45 million, pushing the company’s backlog to an all-time high of $734.32 million—of which roughly 81% is expected to convert to revenue over the next 12 months. The strong 1.26 book-to-bill ratio provides a solid pipeline, particularly for the Aerospace segment (book-to-bill: 1.24; backlog: $651.36 million).
The Test Systems division also showed improvement, with a 15.4% sales uptick and bookings outpacing sales (book-to-bill: 1.55), a clear reversal from past underperformance driven by cost rationalization and operational improvements.
Aerospace Segment Drives Profitability with Margin Expansion and Diversified Growth
Sales in Aerospace rose 11.7%, with strong contributions from Commercial Transport (+13.7%)—especially seat motion and lighting/safety products—and General Aviation (+40.7%). Segment operating profit climbed to $35.33 million (16.5% margin) versus $22.26 million (11.6%) a year earlier. Excluding infrequent litigation and acquisition costs, adjusted Aerospace operating margin reached 17.4%.
General Aviation’s rapid growth was fueled by demand for inflight entertainment and connectivity (IFEC) products, while segment gross margin also advanced to 33.1% from 30.6%. Military Aircraft sales remained steady, and the wind-down of non-core contracts contributed to efficiency gains.
| Aerospace Market | Q1 2026 Sales ($M) | % Change | % of Segment |
|---|---|---|---|
| Commercial Transport | 156.42 | +13.7% | 67.8% |
| Military Aircraft | 33.50 | +0.7% | 14.5% |
| General Aviation | 21.45 | +40.7% | 9.3% |
| Other | 2.45 | -54.0% | 1.1% |
Cash Flow, Balance Sheet, and Capital Investments Support Growth Outlook
Astronics generated $10.61 million in cash from operations, while higher inventories and elevated capital expenditures ($11.16 million) were aimed at powering future growth through operational consolidation and capacity improvements, particularly in Seattle. Available liquidity stood at $231.80 million, with long-term debt relatively stable at $334.89 million.
The company expects to turn more cash-positive in the coming quarters, anticipating full-year 2026 capital expenditures in the range of $40 million–$45 million, primarily connected to facility consolidation and ERP system rollout.
2026 Guidance Raised as Backlog and Bookings Underpin Positive Outlook
Management raised 2026 revenue guidance to a range of $970 million to $1 billion. The midpoint implies a 14% increase over 2025, driven by demand for commercial and defense-related aerospace technologies. Q2 sales are projected at $245–$250 million, on track for a new quarterly record.
The company’s record backlog and steady double-digit growth in both sales and profits set the stage for continued margin improvement and operational leverage. Notably, about 81% of the current backlog is expected to translate into revenue over the next year—a positive sign for both near-term and full-year performance.
Summary: Key Takeaways for Investors
- Broad-based growth: Both Aerospace and Test Systems contributed to gains, with margin and profit expansion outpacing sales growth.
- Record backlog: $734 million in orders provides visibility and underpins management’s higher guidance for the year.
- Improved profitability: Significant jump in margins, net income, and adjusted EBITDA, driven by higher volume and cost controls.
- Cash flow and investments: Short-term working capital build supports longer-term revenue ramp and operational resilience.
- Positive 2026 outlook: Momentum from Q1 and strong demand signals another record year could be in sight for ATRO.
With strong demand across its core markets and a record backlog, Astronics is making a notable case for continued growth, operational leverage, and sustained margin gains through 2026. Investors and analysts may find the company’s ongoing transition and expanded guidance worth following in upcoming quarters.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI